PNEUMOCOCCAL INFECTIOUS DISEASE
Clinical trials for PNEUMOCOCCAL INFECTIOUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL INFECTIOUS DISEASE trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL INFECTIOUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New 24-Strain pneumonia vaccine trial launches for kids
⭐️ VACCINE ⭐️ OngoingThis early-stage trial tests a new vaccine (PCV24) designed to protect children from 24 types of pneumococcal bacteria, which can cause pneumonia, meningitis, and ear infections. About 230 healthy children aged 2 months to 17 years will receive the vaccine or a placebo/control. T…
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE1 • Sponsor: Shanghai Reinovax Biologics Co.,LTD • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 08:30 UTC
-
New vaccine aims to shield adults from 24 pneumococcal strains
⭐️ VACCINE ⭐️ OngoingThis study tests a new vaccine (PCV24) designed to protect against 24 types of pneumococcal bacteria, which can cause pneumonia and other infections. Around 992 adults aged 18 and older in China will receive the vaccine to check its safety and how well it triggers the immune syst…
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE2 • Sponsor: Shanghai Reinovax Biologics Co.,LTD • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 13:54 UTC